Prostate Cancer Clinical Trials in Los Angeles

Showing 201-220 of 280 trials

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

NCT03514927

This phase II trial studies how well high-intensity focused ultrasound works in treating participants with intermediate and high-risk prostate cancer. High-intensity focused ultrasound uses high frequency sound waves to deliver a strong beam which may target and destroy a specific part of the prostate, while minimizing damage to surrounding structures and tissue.

Prostate Cancer Stage I AJCC V6Prostate Cancer Stage IIProstate Cancer Stage III

University of Southern CaliforniaStarted Jul 2019

Los Angeles, California, United States

TERMINATED< 1 mile

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

NCT01727154

The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).

Prostate Cancer

Dendreon139 participantsStarted Oct 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Marina del Rey, California, United States +36 more locations

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Prostate Cancer Trials in Other Cities

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Effect of Weight Loss on Prostate Cancer Pathology

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Use of Hypothermia During Robotic Prostatectomy

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Defining Recurrent Disease With Axumin™

Prospective Validation of Prostate Biomarkers for Repeat Biopsy

Vidaza to Restore Hormone Thx Prostate

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Other Conditions in Los Angeles